These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3244780)

  • 1. The influence of light therapy in depressive patients.
    Fleischhauer J; Glauser G; Hofstetter P
    Pharmacopsychiatry; 1988 Nov; 21(6):414-5. PubMed ID: 3244780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phototherapy as a supporting treatment in depressive patients].
    Sep-Kowalikowa B
    Psychiatr Pol; 2002; 36(6 Suppl):99-108. PubMed ID: 12647428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bright light therapy: side effects and benefits across the symptom spectrum.
    Terman M; Terman JS
    J Clin Psychiatry; 1999 Nov; 60(11):799-808; quiz 809. PubMed ID: 10584776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effects of phototherapy in nonseasonal depressive disorder.
    Volz HP; Mackert A; Stieglitz RD
    Pharmacopsychiatry; 1991 Jul; 24(4):141-3. PubMed ID: 1754611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation.
    Neumeister A; Goessler R; Lucht M; Kapitany T; Bamas C; Kasper S
    Biol Psychiatry; 1996 Jan; 39(1):16-21. PubMed ID: 8719121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sleep deprivation as a predictor of response to light therapy in major depression].
    Heller R; Fritzsche M; Hill H; Kick H
    Fortschr Neurol Psychiatr; 2001 Apr; 69(4):156-63. PubMed ID: 11386120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bright white light on non-seasonal depressive disorder.
    Mackert A; Volz HP; Stieglitz RD; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1990 May; 23(3):151-4. PubMed ID: 2374772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and chronobiological effects of light therapy on nonseasonal affective disorders.
    Yamada N; Martin-Iverson MT; Daimon K; Tsujimoto T; Takahashi S
    Biol Psychiatry; 1995 Jun; 37(12):866-73. PubMed ID: 7548461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bright light augmentation in antidepressant nonresponders.
    Levitt AJ; Joffe RT; Kennedy SH
    J Clin Psychiatry; 1991 Aug; 52(8):336-7. PubMed ID: 1869495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.
    Martiny K; Lunde M; Undén M; Dam H; Bech P
    Acta Psychiatr Scand; 2005 Aug; 112(2):117-25. PubMed ID: 15992393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
    Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
    Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet versus non-ultraviolet light therapy for seasonal affective disorder.
    Lam RW; Buchanan A; Clark CM; Remick RA
    J Clin Psychiatry; 1991 May; 52(5):213-6. PubMed ID: 2033028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major depressive subtypes and treatment response.
    Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
    Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study].
    Cabras PL; Enriques E; Casini A; Paoletti C; Zagnoni P
    Minerva Psichiatr; 1991; 32(2):93-101. PubMed ID: 1870418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.